taxonomy (1)
protein (1)
source (2)
structure (0)
composition (13)
disease (2)
reference (2)
site (2)
peptide (2)
- Homo sapiens (Human)
Taxonomy
Reported structure
- Hex:3 HexNAc:4 NeuAc:2 (avg mass : 1899.7383 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2516.3091 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2590.3886 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 (avg mass : 2881.6465 )
- Hex:6 HexNAc:6 dHex:2 NeuAc:2 (avg mass : 3084.8415 )
- Hex:6 HexNAc:6 dHex:2 NeuAc:3 (avg mass : 3376.0994 )
- Hex:6 HexNAc:6 dHex:4 NeuAc:2 (avg mass : 3377.1275 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:6 dHex:3 NeuAc:1 (avg mass : 3101.869 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:9 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3425.1257 )
Composition
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
Reference
- Thioredoxin domain-containing protein 15 / Homo sapiens
Reported glycosite
- NITGLENFTLK (11aa)
- IFIFNQTGIEAK (12aa)
Mass spectrometry observed peptide
-
- Hex:8 HexNAc:2 / N-Linked (avg mass : 1721.5445)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Thioredoxin domain-containing protein 15 / Homo sapiens
- IFIFNQTGIEAK (12aa)
-
- Hex:9 HexNAc:2 / N-Linked (avg mass : 1883.6869)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Thioredoxin domain-containing protein 15 / Homo sapiens
- IFIFNQTGIEAK (12aa)
-
- Hex:3 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 1899.7383)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Thioredoxin domain-containing protein 15 / Homo sapiens
- IFIFNQTGIEAK (12aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 / N-Linked (avg mass : 2516.3091)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Thioredoxin domain-containing protein 15 / Homo sapiens
- IFIFNQTGIEAK (12aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:1 / N-Linked (avg mass : 2590.3886)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Thioredoxin domain-containing protein 15 / Homo sapiens
- NITGLENFTLK (11aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2735.5035)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Thioredoxin domain-containing protein 15 / Homo sapiens
- NITGLENFTLK (11aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 / N-Linked (avg mass : 2881.6465)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Thioredoxin domain-containing protein 15 / Homo sapiens
- NITGLENFTLK (11aa)
-
- Hex:6 HexNAc:6 dHex:2 NeuAc:2 / N-Linked (avg mass : 3084.8415)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Thioredoxin domain-containing protein 15 / Homo sapiens
- NITGLENFTLK (11aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 3100.8409)
- Mammary Gland (UBERON_0001911)
- Thioredoxin domain-containing protein 15 / Homo sapiens
- NITGLENFTLK (11aa)
-
- Hex:7 HexNAc:6 dHex:3 NeuAc:1 / N-Linked (avg mass : 3101.869)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Thioredoxin domain-containing protein 15 / Homo sapiens
- IFIFNQTGIEAK (12aa)
-
- Hex:6 HexNAc:6 dHex:2 NeuAc:3 / N-Linked (avg mass : 3376.0994)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Thioredoxin domain-containing protein 15 / Homo sapiens
- NITGLENFTLK (11aa)
-
- Hex:6 HexNAc:6 dHex:4 NeuAc:2 / N-Linked (avg mass : 3377.1275)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Thioredoxin domain-containing protein 15 / Homo sapiens
- IFIFNQTGIEAK (12aa)
-
- Hex:9 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 3425.1257)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Thioredoxin domain-containing protein 15 / Homo sapiens
- NITGLENFTLK (11aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
